Home/Filings/4/0001140361-12-051797
4//SEC Filing

SAGER ERICH 4

Accession 0001140361-12-051797

CIK 0001070698other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 9:23 PM ET

Size

17.1 KB

Accession

0001140361-12-051797

Insider Transaction Report

Form 4
Period: 2012-12-17
SAGER ERICH
Director
Transactions
  • Exercise/Conversion

    Stock options (right to buy)

    2012-12-175,828497,328 total
    Exercise: $2.57From: 2007-12-14Exp: 2017-06-13Common Stock (5,828 underlying)
  • Sale

    Common Stock

    2012-12-17$5.43/sh10,984$59,643111,998 total
  • Exercise/Conversion

    Stock options (right to buy)

    2012-12-171,797495,531 total
    Exercise: $2.02From: 2010-09-09Exp: 2020-03-08Common Stock (1,797 underlying)
  • Exercise/Conversion

    Common Stock

    2012-12-17$2.57/sh+9,187$23,611121,185 total
  • Exercise/Conversion

    Common Stock

    2012-12-17$2.02/sh+1,797$3,630122,982 total
  • Sale

    Common Stock

    2012-12-17$5.35/sh3,924$20,993108,074 total
  • Exercise/Conversion

    Stock options (right to buy)

    2012-12-173,359503,156 total
    Exercise: $2.57From: 2006-11-26Exp: 2016-05-25Common Stock (3,359 underlying)
Footnotes (6)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2012.
  • [F2]Original option grant vests 6/36ths on November 26, 2006 and 1/36th per month thereafter.
  • [F3]Original option grants vests 6/48ths on December 14, 2007 and 1/48th per month thereafter.
  • [F4]Original option grants vests 6/48ths on September 9, 2010 and 1/48th per month thereafter.
  • [F5]This transaction was executed in multiple trades at prices ranging from $5.34 to $5.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $5.32 to $5.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Raptor Pharmaceutical Corp

CIK 0001070698

Entity typeother

Related Parties

1
  • filerCIK 0001243489

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 9:23 PM ET
Size
17.1 KB